FDA Adverse Event Injury Summary report: N

AUTOSOFT 90

MDR report key: 22086264 · Received May 27, 2025

Report

Report Number
3003442380-2025-09836
Event Type
Injury
Date Received
May 27, 2025
Date of Event
January 15, 2025
Report Date
July 11, 2025
Manufacturer
UNOMEDICAL DEVICES S.A. DE C.V.
Product Code
FPA
UDI-DI
05705244018150
PMA / PMN Number
K160648
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

SUPPLEMENTAL REPORT 01 - (B)(4) MDR 3003442380-2025-09836. ADDITIONAL INFORMATION - THIS MDR IS BEING SUBMITTED TO INCLUDE THE BELOW: H6: INVESTIGATION RESULTS UNDER TYPE OF INVESTIGATION, INVESTIGATION FINDINGS, INVESTIGATION CONCLUSIONS. H11: INVESTIGATION SUMMARY. COMPLAINT INVESTIGATIONS. A COMPLAINT INVESTIGATION HAS BEEN INITIATED FOR RECORD COMPLAINT (B)(4) ON 10-JUL-2025. DEVICE HISTORY RECORD (DHR) REVIEW: THE LOT 6010027 MANUFACTURED ACCORDING TO THE WORK INSTRUCTION (WI) VERSION 118 ON 08-NOV-2024, WITH A TOTAL OF (B)(4) UNITS. REVIEW OF THE DHR SHOWED THAT ALL RELEVANT TESTS REQUIRED DURING THE RELATED PROCESSES HAD BEEN FULFILLED AND MET THE REQUIREMENTS. NO DEVIATION WAS IDENTIFIED, NOR MAINTENANCE EVENTS WERE RECORDED. TRENDING: A QUERY WAS RUN IN DATABASE ON 09/JUL/2025 AGAINST MALFUNCTION CODE NO MALFUNCTION BASED ON COMPLAINT INFORMATION, HARM CODE INFECTION REQUIRES PRESCRIPTIVE TREATMENT E G ORAL ANTIBIOTICS AND LOT 6010027 AND ONE MORE COMPLAINT HAS BEEN REGISTERED IN DATABSE FOR THE SAME LOT, HARM CODE AND MALFUNCTION CODE. CONCLUSION SUMMARY OF COMPLAINT INVESTIGATION: AS A RESULT OF THE FOLLOWING: NO NON-CONFORMANCE (NC) RAISED DURING PRODUCTION, ONLY ONE COMPLAINT RECEIVED ON THE LOT IN QUESTION AND HARM CODE, THE TEST ON REFERENCE SAMPLES WERE NOT TESTED SINCE A NO MALFUNCTION RELATED TO THE INFUSION SET WAS REPORTED, THEREFORE NO FURTHER ACTIONS ARE REQUIRED. THIS COMPLAINT WILL NOT REQUIRE FURTHER ROOT CAUSE INVESTIGATION NOR CAPA PLAN. THEREFORE, THIS ISSUE WILL BE MONITORED THROUGH THE POST MARKET SURVEILLANCE ACTIVITIES.

Additional Manufacturer Narrative · 0

INITIAL AND FINAL (B)(4) - DEVICE 1 OF 2.

Description of Event or Problem · 0

TO DATE NO ADDITIONAL PATIENT OR EVENT DETAILS HAVE BEEN RECEIVED.

Description of Event or Problem · 0

REFERENCE NUMBER (B)(4). EVENT OCCURED IN THE UNITED STATES. THIS MDR IS BEING SUBMITTED FOR AN UNKNOWN QUANTITY OF INFUSION SETS THAT HAD THE REPORTED ISSUE. ON (B)(6) 2025, THE PATIENT REPORTED DEVELOPING AN INFECTION AT THE SITE WHERE THEIR INFUSION SET WAS INSERTED. THE PATIENT CONSULTED THEIR HEALTHCARE PROVIDER (HCP) ABOUT THE INFECTION. IT WAS NOTED THAT THE INFUSION SET HAD ONLY BEEN IN USE FOR 8 HOURS WHEN THE INFECTION WAS DETECTED. AS A RESULT OF THIS ISSUE, THE PATIENT'S BLOOD GLUCOSE LEVELS BECAME ELEVATED, THOUGH THE EXACT VALUE WAS NOT SPECIFIED; THE METER SIMPLY DISPLAYED 'HIGH'. TO ADDRESS THE HIGH BLOOD GLUCOSE, THE PATIENT ADMINISTERED A CORRECTION DOSE OF INSULIN USING A MULTIPLE DAILY INJECTION (MDI) METHOD. NO FURTHER INFORMATION AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1014512 AUTOSOFT 90 UNO INSET II 110/6 GREY TCAP 10PK INT FPA UNOMEDICAL DEVICES S.A. DE C.V. 1002818 6010027 05705244018150

Patients

Seq Age Sex Outcome Treatment
1 21 YR Female Required Intervention